Skip to main content
PLOS One logoLink to PLOS One
. 2023 May 19;18(5):e0285743. doi: 10.1371/journal.pone.0285743

Molecular detection and antimicrobial resistance profiles of Extended-Spectrum Beta-Lactamase (ESBL) producing Escherichia coli in broiler chicken farms in Malaysia

Mulu Lemlem 1,2,*, Erkihun Aklilu 1,*, Maizan Mohammed 1, Fadhilah Kamaruzzaman 1, Zunita Zakaria 3, Azian Harun 4, Susmita Seenu Devan 1
Editor: Indranil Samanta5
PMCID: PMC10198488  PMID: 37205716

Abstract

Antimicrobial resistance is one of the major public health threats globally. This challenge has been aggravated with the overuse and misuse of antibiotics in food animals and humans. The present study aimed to investigate the prevalence of Extended-Spectrum β-lactamase (ESBL) genes in Escherichia coli (E. coli) isolated from broiler chickens in Kelantan, Malaysia. A total of 320 cloacal swabs were collected from farms in different districts of Kelantan and were analyzed using routine bacteriology, antimicrobial susceptibility test, and molecular techniques for further identification and characterization of ESBL encoding genes. Based on PCR detection for the E. coli species-specific Pho gene, 30.3% (97/320) of isolates were confirmed as E. coli, and 84.5% (82/97) of the isolates were positive for at least one ESBL gene. Majority of the isolates, 62.9% (61/97) were harboring blaCTX-M followed by 45.4% (44/97) of blaTEM genes, while 16.5% (16/97) of the isolates were positive for both mcr-1 and ESBL genes. Overall, 93.8% (90/97) of the E. coli were resistant to three or more antimicrobials; indicating that the isolates were multi-drug resistance. 90.7% of multiple antibiotic resistance (MAR) index value greater than 0.2, would also suggest the isolates were from high-risk sources of contamination. The MLST result shows that the isolates are widely diverse. Our findings provide insight into the alarmingly high distribution of antimicrobial resistant bacteria, mainly ESBL producing E. coli in apparently healthy chickens indicating the role of food animals in the emergence and spread of antimicrobial resistance, and the potential public health threats it may pose.

Introduction

Antimicrobial resistance (AMR) is one of the most challenging threats globally. Excessive use of antimicrobials in veterinary medicine, food-animal production, and agriculture results in the emergence of antimicrobial resistance [13]. Modern food animal production system requires large amounts of antimicrobials for disease control, prophylaxis, and growth promotion. Resistance among bacterial species causes increment in morbidity, mortality, and treatment costs worldwide [4]. Multi-drug resistant bacterial infections can result in minimum treatment choices, thus threats of AMR have reached an alarming level [5].

One of the mechanisms of bacterial resistance to antibiotics is producing an enzyme that hydrolyze the beta-lactam ring of antibiotics. Extended-spectrum β-lactamases are highly potent new bacterial enzymes that are resistant to β-lactam antibiotics [6]. ESBLs are resistant to the three generations of cephalosporin, whereas they might be inhibited by β-lactamase inhibitors specifically clavulanic acid [7]. ESBLs were reported for the first time in 1980s and are responsible for causing nosocomial and community acquired infections. ESBLs are plasmid-encoded enzymes commonly found in Enterobacteriaceae, mainly in E. coli, Klebsiella and Salmonella [8]. E. coli is usually the harmless facultative anaerobic bacteria, which is mostly found in the gastrointestinal tract of humans and animals. However, it is also a potentially pathogenic bacteria that can cause various diseases and is considered as a main cause of mortality and morbidity in poultry farms [9, 10]. Resistant bacteria in food animals may directly or indirectly be transferred to humans through food, water, and manure. Due to the ubiquitous nature of the commensal bacteria, they are reservoirs of resistance determinants [11]. Fecal carriage of extraintestinal pathogenic E coli (EXPEC) associated genes in chicken is found to cause EXPEC infections in animal model [12]. In addition, recent evidences showed that a part of human food born EXPEC infections originated from food producing animals mainly poultry meat [13]. Therefore, identifying these resistant E. coli isolates from apparently healthy food animals is important to understand the antibiotic resistance characteristics, the emergence and spread of resistance genes, particularly ESBL encoding genes. ESBL is an increasing threat for the public health in developing countries including Malaysia. Chicken meat and its products are the main source of protein in Malaysia [14]. There are several reports on the prevalence of ESBL producing E. coli in health sectors in Malaysia [1517]. In addition, recent evidence has shown that there is a high contamination of chicken meat with ESBL producing E. coli in Malaysia [1820]. Even though there is research done in some parts of the peninsular Malaysia on ESBL producing E. coli from chicken farm, but there is no published data on the prevalence of ESBL producing E. coli and its encoding genes from broiler chicken farm in the study area. Therefore, this study was aimed to investigate the occurrence of ESBL producing E. coli, the resistance genes and antimicrobial resistance patterns of E. coli isolated from apparently healthy broiler chickens in Kelantan.

Methodology

Sample collection

A total of 320 cloacal swab samples were randomly collected from 5 different broiler farms namely, Machang, bachok, Tumpat, Pasir Mas and Jeli in Kelantan. Each cloacal swab was placed into Amies transport medium and labeled with sample identification number and date of collection. All collected samples were transported to the laboratory using an ice pack at a temperature of 2–8°C within 6 hours of sample collection.

Isolation and identification of E. coli

Collected cloacal swab samples were enriched in Buffered Peptone Water (Oxoid, Manchester, UK) and incubated at 37°C for 24 hrs. The enriched bacteria were inoculated on MacConkey agar and lactose-fermenting colonies were taken and cultured on Eosin methylene blue (EMB) agar (Oxoid, Manchester, UK) after incubation at 37°C for 24 hrs. Green metallic sheen colonies on EMB were selected for further confirmation by using biochemical characteristics, including triple sugar iron agar (TSI) for glucose fermentation, citrate utilization, urease production, indole fermentation, methyl red test, and motility as mentioned previously [21]. Presumptive E. coli isolates were sub cultured on to nutrient Agar and stored in Luria-Bertani (LB) broth (Oxoid, Manchester, UK) containing 50% glycerol at -80°C for further analysis as described in [22]. E. coli ATCC® 25922 was used as a positive control. Isolates were confirmed by PCR, using a set primer specific for E. coli.

Antimicrobial susceptibility test

Antimicrobial susceptibility testing (AST) of E. coli isolates was performed using the Kirby-Bauer disk diffusion method on Mueller-Hinton agar (MHA) (Oxoid, Manchester, UK). Bacterial suspension with turbidity equivalent to 0.5 McFarland standard was evenly dispensed on the surface of MHA plates using a sterile cotton swab. Antibiotic discs Aztreonam (ATM30), Cefotaxime (CTX30), Amoxicillin-clavulanic acid (AMC30), Ceftazidime (CAZ30), Ceftriaxone (CRO30), Trimethoprim-sulfamethoxazole (SXT25), Chloramphenicol (C30), Tetracycline (TE30), Tazobactam (TZP110), Ofloxacin (OFX5), Imipenem (IPM10) and meropenem (MEM10) were placed on the surface of MHA agar plates and incubated at 37°C for 16 to 18 hours. The zone of inhibition was measured to the nearest millimetre and interpreted based on the guidelines of Clinical and Laboratory Standards Institute (CLSI) [23]. E. coli ATCC® 25922 were used as a control strain. Bacterial isolates that show resistant to three or more classes of antimicrobial agents were classified as multidrug resistant (MDR) [24, 25]. Multiple antibiotic resistance (MAR) index was analyzed as stated in [26]. Multiple antibiotic resistance (MAR) index was calculated by dividing the number of resistant antibiotics which are resistance to an organism to the total number of antibiotics tested.

MARindex=NumberofantimicrobialstowhichtheisolateshowedresistanceNumberoftotalantibioticsexposedtotheisolate

PCR confirmation and ESBL encoding gene detection in E. coli

Genomic DNA was extracted using bacterial DNA extraction kit (Machery-Nagel, Germany) following the manufacturer’s recommendation. Extracted DNA was amplified using PCR with species-specific Pho and E. coli primer as published previously [18, 19, 27, 28]. The primer sequences used in this study are summarized in Table 1. The PCR reaction for pho primer was carried out with the following protocol: An initial denaturation step of 95°C for 4 min followed by 30 cycles of denaturation at 95°C for 30 s, optimized annealing temperature at 56°C for 30 s and extension at 72°C for 60 s with a final extension at 72°C for 10 min. The PCR protocol for E coli primer was as follows: Initial denaturation of 95°C for 3 min; 35 cycles of denaturation at 95°C for 15 sec, annealing at 55°C for 90 sec and extension at 72°C for 15 sec followed by final extension at 72°C for 10 min. Extracted genomic DNA was further amplified using PCR with specific primers (Table 1) to screen for the presence of ESBL (blaCTX-M and blaTEM) and colistin (mcr-1) encoding genes in E. coli. The PCR Protocol used for both CTX and TEM: an initial denaturation 95°C for 4 min, followed by 30 cycles of 94°C denaturation for 30s, 55°C annealing temperature for 30s and extension 72°C for 60 sec, with the final extension 72°C for 10 min. the Agarose gel electrophoresis of the PCR products were conducted, and gel images were analysed using GelDoc© Gel Documentation System (Bio-Rad, USA).

Table 1. Primers used for the detection of E. coli species and ESBL genes.

Target gene  Primer sequence  Amplicon size (bp) Annealing temperature Reference 
Alkaline Phosphatase (Pho A) F: 5′- GTG ACA AAA GCC ACA CCA TAA ATG CCT-3′ 903 56 [18, 27]
R: 3′-TAC ACT GTC ATT ACG TTG CGG ATT TGG CGT-5′ 
E. coli F: 5'-TGACGTTACCCGCAGAAGAA-3' 832 55 [19]
R: 3'-CTCCAATCCGGACTACGACG-5'
bla CTX-M F: 5' -ATG TGC AGY ACC AGT AAR GTK ATG GC-3' 592 60 [29]
R: 3'- TGG GTR AAR TAR GTS ACC AGA AYS AGC GG -5'
bla TEM F:5’-GCG GAA CCC CTA TTT G 964 55
R: 3'-ACC AAT GCT TAA TCA GTG AG-5' 
mcr-1 F: 5'-AGTCCGTTTGTTCTTGTGGC-3' 320 58 [30]
R: 3'-AGATCCTTGGTCTCGGCTTG-5'

A correlation heatmap was generated between the antibiotic resistance genes and resistance phenotypes using a Python seaborn library for categorical variables [31]. The phenotype resistance of the antibiotics was determined based antibiotic susceptibility profiles.

Multi-Locus sequence typing (MLST)

Seven housekeeping genes, adk, fumC, gyrB, icd, mdh, purA, and recA, were amplified and sequenced for each selected isolates following previous protocol [32, 33].The primers used are available online in website [34]. The PCR conditions were as follows: initial denaturation at 95°C for 2 min; 30 cycles of 95°C for 1 min, 56°C (adk) or 64°C (fumC, and purA) or 68°C (recA, gyrB, icd and mdh) for 1 min and 72°C for 2 min; followed by a final extension step at 72°C for 5 min. The amplified PCR products were sent to Apical 1st base Sequencing service (Apical Scientific SDN. BHD.) Malaysia, to perform a sequence analysis. The allele sequences and sequence types were determined from the E. coli database at the MLST website [35].

Ethical approval

This study was approved by the Institutional Animal Care and Use Committee of Universiti Malaysia Kelantan (Approval code: UMK/FPV/ACUE/PG/2/2019, Approval Date: February 2019). The animal subjects (chicken from commercial poultry farms) were used only for cloacal swabs collection and no invasive or harmful procedures were used in handling the birds.

Result

In this study, out of 320 cloacal swab samples, 121 presumptive E. coli were isolated based on routine bacteriological and biochemical characteristics. Out of these 121 E. coli isolates, from Machang were (n = 35), Bachok (n = 28), Tumpat (n = 20), Pasir Mas (n = 21) and Jeli (n = 17). Out of these E. coli isolates, 30% (97/320) were confirmed as E. coli by PCR using species-specific primer.

Antimicrobial susceptibility profile

Antimicrobial susceptibility pattern of the E. coli isolates against 12 antibiotics of different classes were subjected and the results are summarized in Table 2. E. coli isolates had relatively higher resistance to tetracycline (82.5%) and sulfamethoxazole/trimethoprim (78.4%), whereas the lowest resistance (17.5%) was observed to the imipenem as shown in Table 2. In addition, some of the E. coli isolates were resistant to carbapenem antibiotics, meropenem (28.9%) and imipenem (17.5%). Almost all, 93.8% (91/97) of the isolates were resistant to at least three of the tested 12 antibiotic discs belong to different classes. Thus, they could be classified most of the E. coli isolates of this study are multi-drug resistant. 90.7% of the isolates were with MAR index values > 0.2; while 9.3% of them had index values less than or equal to 0.2. The proportions of isolates with the MAR index values from 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, and 0.9 were 16.5%,16.5%,7.2%, 15.5%,10.3%, 12.4% and 8.3% respectively.

Table 2. Antimicrobial resistance profiles of E. coli isolate from chicken farm in Kelantan, Malaysia, 2021 (n = 97).

Antibiotic Antibiotic class R R (%)
Imipenem (IPM10) Carbapenem 17 17.5
Meropenem (MEM10) Carbapenem 28 28.9
Tazobactam (TZP110) Beta-lactamase inhibitor 36 37.1
Ceftazidime (CAZ30) Cephalosporin  46 47.4
Aztreonam (ATM30) Beta-lactam 49 50.5
Cefotaxime (CTX30) Cephalosporin  51 52.6
Ofloxacin (OFX5) Quinolones 58 59.8
Amoxicillin-clavulanic acid (AMC30) Beta-lactamase inhibitor 59 60.8
Ceftriaxone (CRO30) Cephalosporin  60 61.9
Chloramphenicol(C30) Chloramphenicol 60 61.9
Trimethoprim-sulfamethoxazole (SXT25) Sulphonamides 76 78.4
Tetracycline (TE30) Tetracycline  80 82.5

ESBL encoding genes in E. coli isolates

The E. coli isolates were screened for the presence of ESBL encoding genes where blaCTX-M and blaTEM genes were detected in 62.9% (61/97) and 45.4% (44/97) of the samples respectively. In addition, 20.6% (20/97) were positive for colistin resistance gene mcr-1. Our study showed that 22.7% (22/97) of the E. coli isolates were harboring both blaCTX-M and blaTEM genes. The majority the ESBL resistance genes found were blaCTX-M gene. Six isolates (6.1%) were found positive for blaCTX-M, blaTEM and mcr-1 genes. Overall, 84.5% (82/97) of those E. coli isolates were positive for ESBL genes. The ESBL and colistin resistance genes distribution are summarized in Table 3.

Table 3. MLST sequence type of E. coli isolates and encoding resistance genes.

Sample ID ST ST complex ESBL Gene
KT10 ST93 ST168CPLX bla CTX
Cs8 STX ST540 mcr-1
KT15 ST373 ST168copmlex mcr-1
KT18 ST69 ST69 complex bla TEM
KT9 ST154 mcr-1
KT3R ST93 ST168comlex mcr-1
KT22R ST226 ST226 complex bla TEM
Cs8 ST117 blaCTX, blaTEM
KT33 ST345 blaCTX, blaTEM, mcr-1
CS34 ST196 blaTEM, mcr-1
CS32STK ST1001 blaCTX, blaTEM, mcr-1
KT23-26/2 ST155 ST155cplx blaCTX, blaTEM, mcr-1
KT32R ST345 blaCTX, blaTEM, mcr-1
JL24 ST1638 ST10cplx blaCTX, blaTEM, mcr-1

Multi-Locus sequence typing (MLST)

The MLST sequence typing of the isolates shows that the E. coli isolates were widely diverse.

The Identified sequence types are summarized in Table 3.

The correlation coefficient of the phenotype resistant to ESBL Encoding (blaCTX-M and blaTEM) genes of the isolated E. coli shows near to zero value (Fig 1). However, the a few resistance antibiotics, for instance, CAZ30 and CTX30; CRO30 and CTX30; ATM30 and CAZ30; TZP110 and CAZ30 have shown a strong correlation pattern.

Fig 1. Correlation heatmap for ESBL genes with antibiotic resistant phenotypes.

Fig 1

Discussion

Even though E. coli is a commensal bacterium, it is the main opportunistic pathogen in poultry. ESBL producing E. coli pose major threat to poultry production with a potential risk of transfer of these resistant pathogens to humans directly or indirectly. In the present study, ESBL encoding genes of E. coli were detected from cloacal swab samples collected from broiler chickens in Kelantan, Malaysia. The 30% prevalence of E. coli among the samples collected from the broiler chicken farm in the current study is lower than the previous study from Malaysia which reported a prevalence of 82.3% [36] and 72.8% [37]. This difference in E. coli isolation could be due to the difference in the sample size, the types of samples and sampling area used in the research. For instance, the result from [37] includes environmental and cloacal samples and [38] used only 88 chicken cloacal samples in their study.

Antimicrobial resistance in broiler chickens has been reported in many countries in the world. This could be due to the rampant use of antibiotics as growth promoter, disease prevention and treatment of diseases in food animals. Our result revealed that most of the isolates were resistant in different degrees to commonly used antibiotics such as, tetracycline (82.5%), trimethoprim-sulphamethoxazole (78.4%) and chloramphenicol (61.9%). These results showed that most of the isolated E. coli from broilers in the chicken farms were multidrug-resistant. The excessive uses of these common antimicrobials in the poultry production has been reported to cause multidrug-resistance [39]. High resistance rate of tetracycline and sulfamethoxazole/trimethoprim, 91.4% and 74.2% respectively, were reported from previous study on broiler chicken farm from Malaysia [37]. In our study, some E. coli isolates show resistant to carbapenem antibiotics, meropenem (28.9%) and imipenem (17.5%). In this study isolates with MAR index values greater than 0.2 were 90.7%, and 9.3% were less than or equal to 0.2. The high percentage of MAR indices with values greater than 0.2 indicates that the isolates originate from high-risk sources of contamination. This might be caused by the excessive usage of antibiotics for prevention, control of diseases, and growth promotion [40]. E. coli isolates were positive for ESBL encoding genes, blaCTX-M and blaTEM. This finding suggests that ESBL producing E. coli is distributed in local broiler farms. Spread of ESBL-producing E. coli isolates from non-symptomatic food animals indicates that commensal E. coli can serve as a resistance gene reservoir and may pose a potential risk of transfer to humans [41, 42]. Previous studies from Malaysia showed high prevalence of ESBL as well as colistin resistant E. coli contamination from chicken meat [1820].

In our study the dominant ESBL encoding gene was blaCTX-M, which was also reported by several studies conducted in broilers globally [36, 38, 4245]. Recently blaCTX-M is reported the leading ESBL gene worldwide. In contrast to this, a study from Germany showed blaSHV was the most prevalent ESBL gene in poultry [46]. We found that out of the 97 isolates of E. coli, blaCTX-M genes were detected in 62.9% of the isolates. This finding is slightly higher than previous prevalence reports from similar work by Khoshbakht R [47] which reported 60.3% prevalence of blaCTX-M producing E. coli in chicken from Iran. Similar patterns of prevalence were recently reported in Malaysia by [36] who reported that 100% (7/7) E. coli were positive for blaCTX-M genes. The presence of blaTEM in the E. coli isolated from chicken of this study was 45.4%, which is higher than a study from Iran (37.7%) [47], but it is slightly lower than Enterobacteriaceae isolated from surface water in Malaysia (47.4%). Similarly, it has been reported that high prevalence of blaCTX-M followed by blaTEM harboring E. coli recovered from human clinical samples [48, 49]. We found that 22.7% of the E. coli isolates were encoding both blaCTX-M and blaTEM ESBL genes, which is slightly lower than previous study from Philippines, 33.3% [42]. Evidences show that ESBL prevalence varies throughout the world where Asian countries were with the highest rates [50]. In addition, we detected the coexistence of mcr-1 gene with blaCTX-M in six of the E coli isolates. Which shows that, the co- resistance of another critical antibiotic, colistin. Similar findings were also reported from studies of chicken origin in Nepal and China [44, 51]. The correlation analysis of resistance antibiotic phenotypes with blaCTX-M and blaTEM genotypes did not show any correlations. Whereas, a strong correction was observed among cephalosporins, cephalosporin versus beta-lactam and beta-lactam inhibitor.

In this study the MLST sequence typing of the isolates shows that the E. coli isolates were widely diverse. Among the sequences, medically important groups like ST117, ST69 and ST155 were identified. ST117 and ST155 E. coli isolates were harboring both blaCTX and blaTEM ESBL genes. Both ST117 and ST155 were found in ESBL-producing E. coli from community in Malaysia [52]. ST117 was reported in extraintestinal pathogenic E. coli related virulence genes both in human and food-animal [53]. ST 155 were also reported in broiler chicken origin from previous research from Malaysia [20]. It was also reported with ESBL producing E.coli isolates in chicken meat in Singapore, Spain [54, 55] and from diseased chicken in China [56]. ST69 (ST69 complex) was also found harboring blaTEM gene.

Both ST117 and ST69 were reported from human EXPEC associated infections and food animals and retail meat sources in Europe [57]. In addition, ST69 was found with high virulence gene content in human EXPE in Spain [58].

Conclusion

This study showed that prevalence of ESBL genes in E. coli isolates from broilers chicken farms in Malaysia is high. Our finding shows that blaCTX-M is the most prevalent ESBL gene in broiler farms in Kelantan, Malaysia. Most of the E. coli isolates were multi-drug resistant and are therefore a potential risk as sources of ESBL producing E. coli infection from animals to humans by direct or indirect consumption of the animal products. The findings provide an insight that ESBL producing E. coli is likely spreading among the local chicken farms in Malaysia, particularly Kelantan. The spread of this multidrug resistant E. coli in food animals poses a risk of dissemination of the pathogen to humans through food chain.

Supporting information

S1 Data. Contains all supplementary data.

(CSV)

S1 File. Contains all the supporting figures.

(DOCX)

S2 File. Contain the correlation matrix.

(IPYNB)

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The authors would like to thank the Faculty of Veterinary Medicine, Universiti Malaysia Kelantan for providing research facility to conduct the research. The laboratory investigation of this research was funded by Ministry of Higher Education Malaysia (MOHE) under the fundamental research grant scheme (FRGS), grant no. R/FRGS/A0600/00553A/005/2019/00700 awarded to Dr Erkihun Aklilu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Cabello FC. Heavy use of prophylactic antibiotics in aquaculture: a growing problem for human and animal health and for the environment. Environ Microbiol. 2006;8(7):1137–44. Epub 2006/07/05. doi: 10.1111/j.1462-2920.2006.01054.x . [DOI] [PubMed] [Google Scholar]
  • 2.Rantala M, Holso K, Lillas A, Huovinen P, Kaartinen L. Survey of condition-based prescribing of antimicrobial drugs for dogs at a veterinary teaching hospital. Vet Rec. 2004;155(9):259–62. Epub 2004/10/06. doi: 10.1136/vr.155.9.259 . [DOI] [PubMed] [Google Scholar]
  • 3.Schwarz S, Kehrenberg C, Walsh TR. Use of antimicrobial agents in veterinary medicine and food animal production. Int J Antimicrob Agents. 2001;17(6):431–7. Epub 2001/06/09. doi: 10.1016/s0924-8579(01)00297-7 . [DOI] [PubMed] [Google Scholar]
  • 4.Bunner CA, Norby B, Bartlett PC, Erskine RJ, Downes FP, Kaneene JB. Prevalence and pattern of antimicrobial susceptibility in Escherichia coli isolated from pigs reared under antimicrobial-free and conventional production methods. J Am Vet Med Assoc. 2007;231(2):275–83. Epub 2007/07/17. doi: 10.2460/javma.231.2.275 . [DOI] [PubMed] [Google Scholar]
  • 5.Wall B, Mateus A, Marshall L, Pfeiffer D, Lubroth J, Ormel H, et al. Drivers, dynamics and epidemiology of antimicrobial resistance in animal production: Food and Agriculture Organization of the United Nations; 2016. [Google Scholar]
  • 6.Shaikh S, Fatima J, Shakil S, Rizvi SM, Kamal MA. Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. Saudi J Biol Sci. 2015;22(1):90–101. Epub 2015/01/07. doi: 10.1016/j.sjbs.2014.08.002 ; PubMed Central PMCID: PMC4281622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Bush K, Jacoby GA. Updated functional classification of beta-lactamases. Antimicrob Agents Chemother. 2010;54(3):969–76. Epub 2009/12/10. doi: 10.1128/AAC.01009-09 ; PubMed Central PMCID: PMC2825993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Bajpai T, Pandey M, Varma M, Bhatambare GS. Prevalence of TEM, SHV, and CTX-M Beta-Lactamase genes in the urinary isolates of a tertiary care hospital. Avicenna J Med. 2017;7(1):12–6. Epub 2017/02/10. doi: 10.4103/2231-0770.197508 ; PubMed Central PMCID: PMC5255976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, et al. Health care—associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137(10):791–7. Epub 2002/11/19. doi: 10.7326/0003-4819-137-10-200211190-00007 . [DOI] [PubMed] [Google Scholar]
  • 10.Kathayat D, Helmy YA, Deblais L, Rajashekara G. Novel small molecules affecting cell membrane as potential therapeutics for avian pathogenic Escherichia coli. Sci Rep. 2018;8(1):15329. Epub 2018/10/20. doi: 10.1038/s41598-018-33587-5 ; PubMed Central PMCID: PMC6193035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Schaefer AM, Bossart GD, Mazzoil M, Fair PA, Reif JS. Risk factors for colonization of E. coli in Atlantic Bottlenose Dolphins (Tursiops truncatus) in the Indian River Lagoon, Florida. J Environ Public Health. 2011;2011:597073. Epub 2011/10/07. doi: 10.1155/2011/597073 ; PubMed Central PMCID: PMC3184408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Stromberg ZR, Johnson JR, Fairbrother JM, Kilbourne J, Van Goor A, Curtiss RR, et al. Evaluation of Escherichia coli isolates from healthy chickens to determine their potential risk to poultry and human health. PLoS One. 2017;12(7):e0180599. Epub 2017/07/04. doi: 10.1371/journal.pone.0180599 ; PubMed Central PMCID: PMC5495491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Lazarus B, Paterson DL, Mollinger JL, Rogers BA. Do human extraintestinal Escherichia coli infections resistant to expanded-spectrum cephalosporins originate from food-producing animals? A systematic review. Clin Infect Dis. 2015;60(3):439–52. Epub 2014/10/11. doi: 10.1093/cid/ciu785 . [DOI] [PubMed] [Google Scholar]
  • 14.Wahab A, Rittgers C. Broiler Meat Sector, Malaysia. USDA Foreign Agricultural Service. 2014. [Google Scholar]
  • 15.Lim KT, Yasin R, Yeo CC, Puthucheary S, Thong KL. Characterization of multidrug resistant ESBL-producing Escherichia coli isolates from hospitals in Malaysia. J Biomed Biotechnol. 2009;2009:165637. Epub 2009/08/13. doi: 10.1155/2009/165637 ; PubMed Central PMCID: PMC2721974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ngoi ST, Teh CSJ, Chong CW, Abdul Jabar K, Tan SC, Yu LH, et al. In Vitro Efficacy of Flomoxef against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Associated with Urinary Tract Infections in Malaysia. Antibiotics (Basel). 2021;10(2):181. Epub 2021/03/07. doi: 10.3390/antibiotics10020181 ; PubMed Central PMCID: PMC7916913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Ho WS, Balan G, Puthucheary S, Kong BH, Lim KT, Tan LK, et al. Prevalence and characterization of multidrug-resistant and extended-spectrum beta-lactamase-producing Escherichia coli from pediatric wards of a Malaysian hospital. Microb Drug Resist. 2012;18(4):408–16. Epub 2012/03/08. doi: 10.1089/mdr.2011.0222 . [DOI] [PubMed] [Google Scholar]
  • 18.Aklilu E, Raman K. MCR-1 Gene Encoded Colistin-Resistant Escherichia coli in Raw Chicken Meat and Bean Sprouts in Malaysia. Int J Microbiol. 2020;2020:8853582. Epub 2020/08/11. doi: 10.1155/2020/8853582 ; PubMed Central PMCID: PMC7407033 publication of this paper. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Aliyu AB, Saleha AA, Jalila A, Zunita Z. Risk factors and spatial distribution of extended spectrum beta-lactamase-producing- Escherichia coli at retail poultry meat markets in Malaysia: a cross-sectional study. BMC Public Health. 2016;16(1):699. Epub 2016/08/04. doi: 10.1186/s12889-016-3377-2 ; PubMed Central PMCID: PMC4971674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Aklilu E, Harun A, Singh KKB. Molecular characterization of blaNDM, blaOXA-48, mcr-1 and blaTEM-52 positive and concurrently carbapenem and colistin resistant and extended spectrum beta-lactamase producing Escherichia coli in chicken in Malaysia. BMC Vet Res. 2022;18(1):190. Epub 2022/05/20. doi: 10.1186/s12917-022-03292-7 ; PubMed Central PMCID: PMC9118571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Liu X, Liu H, Li Y, Hao C. Association between virulence profile and fluoroquinolone resistance in Escherichia coli isolated from dogs and cats in China. The Journal of Infection in Developing Countries. 2017;11(04):306–13. doi: 10.3855/jidc.8583 [DOI] [PubMed] [Google Scholar]
  • 22.Yin W, Li H, Shen Y, Liu Z, Wang S, Shen Z, et al. Novel plasmid-mediated colistin resistance gene mcr-3 in Escherichia coli. MBio. 2017;8(3):e00543–17. doi: 10.1128/mBio.00543-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.CSLI. Performance Standard for Antimicrobial Suseceptibility Testing.31st ed. CLSI supliment M100Clinical and Laboratory Standards Institute 2021. [Google Scholar]
  • 24.Schwarz S, Silley P, Simjee S, Woodford N, van Duijkeren E, Johnson AP, et al. Editorial: assessing the antimicrobial susceptibility of bacteria obtained from animals. J Antimicrob Chemother. 2010;65(4):601–4. Epub 2010/02/26. doi: 10.1093/jac/dkq037 . [DOI] [PubMed] [Google Scholar]
  • 25.Sweeney MT, Lubbers BV, Schwarz S, Watts JL. Applying definitions for multidrug resistance, extensive drug resistance and pandrug resistance to clinically significant livestock and companion animal bacterial pathogens. J Antimicrob Chemother. 2018;73(6):1460–3. Epub 2018/02/27. doi: 10.1093/jac/dky043 . [DOI] [PubMed] [Google Scholar]
  • 26.Osundiya O, Oladele R, Oduyebo O. Multiple antibiotic resistance (MAR) indices of Pseudomonas and Klebsiella species isolates in Lagos University Teaching Hospital. African Journal of Clinical and Experimental Microbiology. 2013;14(3):164–8. [Google Scholar]
  • 27.Thong KXYaKL. Multiplex PCR for simultaneous detection of virulence Genes in Escherichia coli. Malaysian Journal of Science. 2009;28(1):1–14. [Google Scholar]
  • 28.Kong RYC, So CL, Law WF, Wu RSS. A Sensitive and Versatile Multiplex PCR System for the Rapid Detection of Enterotoxigenic (ETEC), Enterohaemorrhagic (EHEC) and Enteropathogenic (EPEC) Strains of Escherichia coli. Marine Pollution Bulletin. 1999;38(12):1207–15. doi: 10.1016/s0025-326x(99)00164-2 [DOI] [Google Scholar]
  • 29.Dierikx C, van Essen-Zandbergen A, Veldman K, Smith H, Mevius D. Increased detection of extended spectrum beta-lactamase producing Salmonella enterica and Escherichia coli isolates from poultry. Vet Microbiol. 2010;145(3–4):273–8. Epub 2010/04/17. doi: 10.1016/j.vetmic.2010.03.019 . [DOI] [PubMed] [Google Scholar]
  • 30.Rebelo AR, Bortolaia V, Kjeldgaard JS, Pedersen SK, Leekitcharoenphon P, Hansen IM, et al. Multiplex PCR for detection of plasmid-mediated colistin resistance determinants, mcr-1, mcr-2, mcr-3, mcr-4 and mcr-5 for surveillance purposes. Euro Surveill. 2018;23(6):29–39. Epub 2018/02/15. doi: 10.2807/1560-7917.ES.2018.23.6.17-00672 ; PubMed Central PMCID: PMC5824125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Waskom M. seaborn: statistical data visualization. Journal of Open Source Software. 2021;6(60)), 3021,. doi: 10.21105/joss.03021 [DOI] [Google Scholar]
  • 32.Seenama C, Thamlikitkul V, Ratthawongjirakul P. Multilocus sequence typing and bla ESBL characterization of extended-spectrum beta-lactamase-producing Escherichia coli isolated from healthy humans and swine in Northern Thailand. Infect Drug Resist. 2019;12:2201–14. Epub 2019/08/15. doi: 10.2147/IDR.S209545 ; PubMed Central PMCID: PMC6650452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Tartof SY, Solberg OD, Manges AR, Riley LW. Analysis of a uropathogenic Escherichia coli clonal group by multilocus sequence typing. J Clin Microbiol. 2005;43(12):5860–4. Epub 2005/12/08. doi: 10.1128/JCM.43.12.5860-5864.2005 ; PubMed Central PMCID: PMC1317175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, et al. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol. 2006;60(5):1136–51. Epub 2006/05/13. doi: 10.1111/j.1365-2958.2006.05172.x ; PubMed Central PMCID: PMC1557465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.EnteroBase. Escherichia coli MLST Database. 2018. [cited 2022 20 August]. Available from: https://enterobase.warwick.ac.uk/species/ecoli/allele_st_search. [Google Scholar]
  • 36.Suryadevara N, Yong K, Balavinayagamani G, Subramonie S, Ragavan ND, Ramachandiran M, et al. Molecular characterization of Escherichia coli from chickens in poultry farms of Malaysia. Research journal of biotechnology. 2020;15:1–10. [Google Scholar]
  • 37.Elmi SA, Simons D, Elton L, Haider N, Abdel Hamid MM, Shuaib YA, et al. Identification of Risk Factors Associated with Resistant Escherichia coli Isolates from Poultry Farms in the East Coast of Peninsular Malaysia: A Cross Sectional Study. Antibiotics (Basel). 2021;10(2). Epub 2021/02/04. doi: 10.3390/antibiotics10020117 ; PubMed Central PMCID: PMC7912622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Nagaraja Suryadevara KBY, Balavinayagamani Ganapathy, Sridevi Subramonie, Nanthiney Devi Ragavan MR, Gnanendra Shanmugam and Ponmurugan P. Extended-spectrum beta-lactam antibiotics have widely been used for treatment of serious Gram-negative infections. However, bacterial resistance has emerged due to production of extended-spectrum beta-lactamases (ESBLs). Research Journal of Biotechnology. 2020. [Google Scholar]
  • 39.McEwen SA, Fedorka-Cray PJ. Antimicrobial use and resistance in animals. Clin Infect Dis. 2002;34 Suppl 3(Supplement_3):S93–S106. Epub 2002/05/04. doi: 10.1086/340246 . [DOI] [PubMed] [Google Scholar]
  • 40.Krumperman PH. Multiple antibiotic resistance indexing of Escherichia coli to identify high-risk sources of fecal contamination of foods. Appl Environ Microbiol. 1983;46(1):165–70. Epub 1983/07/01. doi: 10.1128/aem.46.1.165-170.1983 ; PubMed Central PMCID: PMC239283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Li S, Zhao M, Liu J, Zhou Y, Miao Z. Prevalence and Antibiotic Resistance Profiles of Extended-Spectrum beta-Lactamase-Producing Escherichia coli Isolated from Healthy Broilers in Shandong Province, China. J Food Prot. 2016;79(7):1169–73. Epub 2016/07/01. doi: 10.4315/0362-028X.JFP-16-025 . [DOI] [PubMed] [Google Scholar]
  • 42.Gundran RS, Cardenio PA, Villanueva MA, Sison FB, Benigno CC, Kreausukon K, et al. Prevalence and distribution of blaCTX-M, blaSHV, blaTEM genes in extended- spectrum beta- lactamase- producing E. coli isolates from broiler farms in the Philippines. BMC Vet Res. 2019;15(1):227. Epub 2019/07/07. doi: 10.1186/s12917-019-1975-9 ; PubMed Central PMCID: PMC6612079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Hiroi M, Yamazaki F, Harada T, Takahashi N, Iida N, Noda Y, et al. Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in food-producing animals. J Vet Med Sci. 2012;74(2):189–95. Epub 2011/10/08. doi: 10.1292/jvms.11-0372 . [DOI] [PubMed] [Google Scholar]
  • 44.Wu C, Wang Y, Shi X, Wang S, Ren H, Shen Z, et al. Rapid rise of the ESBL and mcr-1 genes in Escherichia coli of chicken origin in China, 2008–2014. Emerg Microbes Infect. 2018;7(1):30. Epub 2018/03/15. doi: 10.1038/s41426-018-0033-1 ; PubMed Central PMCID: PMC5849743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Horton RA, Randall LP, Snary EL, Cockrem H, Lotz S, Wearing H, et al. Fecal carriage and shedding density of CTX-M extended-spectrum {beta}-lactamase-producing escherichia coli in cattle, chickens, and pigs: implications for environmental contamination and food production. Appl Environ Microbiol. 2011;77(11):3715–9. Epub 2011/04/12. doi: 10.1128/AEM.02831-10 ; PubMed Central PMCID: PMC3127594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Dahms C, Hubner NO, Kossow A, Mellmann A, Dittmann K, Kramer A. Occurrence of ESBL-Producing Escherichia coli in Livestock and Farm Workers in Mecklenburg-Western Pomerania, Germany. PLoS One. 2015;10(11):e0143326. Epub 2015/11/26. doi: 10.1371/journal.pone.0143326 ; PubMed Central PMCID: PMC4659621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Khoshbakht R SS, Raeisi M. Antibiotic susceptibility and high prevalence of extended spectrum beta-lactamase producing Escherichia coli in iranian broilers. Revue Méd Vét. 2016. [Google Scholar]
  • 48.Sekawi Z, Yusof R, Shamsudin M. Extended-spectrum β-lactamases-producing Escherichia coli from a tertiary hospital in Malaysia: emergence of CTX-M-type β-lactamases variation. Research Journal of Microbiology. 2008;3:489–93. [Google Scholar]
  • 49.Pokhrel RH, Thapa B, Kafle R, Shah PK, Tribuddharat C. Co-existence of beta-lactamases in clinical isolates of Escherichia coli from Kathmandu, Nepal. BMC Res Notes. 2014;7(1):694. Epub 2014/10/08. doi: 10.1186/1756-0500-7-694 ; PubMed Central PMCID: PMC4197279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Hawkey PM. Prevalence and clonality of extended-spectrum beta-lactamases in Asia. Clin Microbiol Infect. 2008;14 Suppl 1:159–65. Epub 2007/12/25. doi: 10.1111/j.1469-0691.2007.01855.x . [DOI] [PubMed] [Google Scholar]
  • 51.Joshi PR, Thummeepak R, Paudel S, Acharya M, Pradhan S, Banjara MR, et al. Molecular Characterization of Colistin-Resistant Escherichia coli Isolated from Chickens: First Report from Nepal. Microb Drug Resist. 2019;25(6):846–54. Epub 2019/03/16. doi: 10.1089/mdr.2018.0326 . [DOI] [PubMed] [Google Scholar]
  • 52.Dwiyanto J, Hor JW, Reidpath D, Su TT, Lee SWH, Ayub Q, et al. Pan-genome and resistome analysis of extended-spectrum ss-lactamase-producing Escherichia coli: A multi-setting epidemiological surveillance study from Malaysia. PLoS One. 2022;17(3):e0265142. Epub 2022/03/11. doi: 10.1371/journal.pone.0265142 ; PubMed Central PMCID: PMC8912130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Manges AR, Harel J, Masson L, Edens TJ, Portt A, Reid-Smith RJ, et al. Multilocus sequence typing and virulence gene profiles associated with Escherichia coli from human and animal sources. Foodborne Pathog Dis. 2015;12(4):302–10. Epub 2015/03/17. doi: 10.1089/fpd.2014.1860 . [DOI] [PubMed] [Google Scholar]
  • 54.Guo S, Aung KT, Leekitcharoenphon P, Tay MYF, Seow KLG, Zhong Y, et al. Prevalence and genomic analysis of ESBL-producing Escherichia coli in retail raw meats in Singapore. J Antimicrob Chemother. 2021;76(3):601–5. Epub 2020/12/18. doi: 10.1093/jac/dkaa461 . [DOI] [PubMed] [Google Scholar]
  • 55.Vitas AI, Naik D, Perez-Etayo L, Gonzalez D. Increased exposure to extended-spectrum beta-lactamase-producing multidrug-resistant Enterobacteriaceae through the consumption of chicken and sushi products. Int J Food Microbiol. 2018;269:80–6. Epub 2018/02/09. doi: 10.1016/j.ijfoodmicro.2018.01.026 . [DOI] [PubMed] [Google Scholar]
  • 56.Ding S, Han X, Li J, Gao W, Chen Z, Feng Y. Discovery of multi-drug resistant, MCR-1 and ESBL-coproducing ST117 Escherichia coli from diseased chickens in northeast China. Science Bulletin. 2018;63(16):1059–66. doi: 10.1016/j.scib.2018.07.017 [DOI] [PubMed] [Google Scholar]
  • 57.Manges AR. Escherichia coli and urinary tract infections: the role of poultry-meat. Clin Microbiol Infect. 2016;22(2):122–9. Epub 2015/12/19. doi: 10.1016/j.cmi.2015.11.010 . [DOI] [PubMed] [Google Scholar]
  • 58.Blanco J, Mora A, Mamani R, Lopez C, Blanco M, Dahbi G, et al. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain. J Antimicrob Chemother. 2011;66(9):2011–21. Epub 2011/06/15. doi: 10.1093/jac/dkr235 . [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Indranil Samanta

16 Jan 2023

PONE-D-22-25669Molecular Detection and Antimicrobial Resistance Profiles of Extended-Spectrum Beta-Lactamase (ESBL) Producing Escherichia coli in Broiler Chicken Farms in MalaysiaPLOS ONE

Dear Dr. Desta,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR: Point wise reply/rebuttal of the reviewer's comments should be done

==============================

Please submit your revised manuscript by Mar 02 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Indranil Samanta

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf

and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

3. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“The authors would like to thank the Faculty of Veterinary Medicine, Universiti Malaysia Kelantan for providing research facility to conduct the research. This research was funded by Ministry of Higher Education Malaysia (MOHE) under the fundamental research grant scheme (FRGS), grant no. R/FRGS/A0600/00553A/005/2019/00700.”

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“The authors would like to thank the Faculty of Veterinary Medicine, Universiti Malaysia Kelantan for providing research facility to conduct the research. This research was funded by Ministry of Higher Education Malaysia (MOHE) under the fundamental research grant scheme (FRGS), grant no. R/FRGS/A0600/00553A/005/2019/00700 awarded to Dr Erkihun Aklilu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

5. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section.

Additional Editor Comments:

Point wise reply/rebuttal of the reviewer's comments should be made

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The following corrections are to be made.

Line 17- excessive may be exchanged with overuse.

Line 38: Modern food animal production system requires large amounts

Line 49: also found in Salmonella

Line 53: directly or indirectly be transferred to humans through (happens vice versa)

Line 66: from chicken farm but there is no

Line 68: Therefore, this study was aimed

Line 75: in Amies transport medium and labeled

Line 80: 24 hrs.

Line 82: 24 hrs.

Line 83: confirmation by using biochemical characteristics

Line 86: Agar

Line 114: 4 min,

Line 115: 60 sec and 10 mins

Line 122: The primers used are available in (correct the language)

Line 137: isolates will be in non italic

Line 153: Our study showed that

Line 179: These results showed that most

Line 198: We found that out of the 97 isolates of E. coli,

Please check all references font and style.

Reviewer #2: The above-entitled manuscript by Mulu Lemlem Desta et al., evaluated the antimicrobial resistant profiles of Escherichia coli bacteria isolated from broiler chicken farms in Malaysia.

The manuscript is well-written. I suggest the following points to be considered before deciding this manuscript for publication:

1. Page 11, Line 102-03: Please provide brief description how Multiple antibiotic resistance (MAR) index was analyzed.

2. Some anomalies of reference citation were noticed. Reference numbers # 27 and #28 are the publications shown differently. Similar anomalies might be present. Please provide some other stronger references that attest 'Pho-gene" specific E. coli detection. Please include 16s rDNA gene sequence to confirm E. coli.

3. Please provide a supplementary figure stating cultural, biochemical characteristics, antimicrobial susceptibility analyses, and Polymerase chain reaction results for different genes described in the manuscript.

4. At page 14, line 140-41, described higher resistance of the E. coli isolates against meropenem (28.9%) than that of imipenem (17.5%) is unusual. Need to reinvestigate the findings.

5. Table 2 has described both the resistant and susceptible frequency. As resistant frequency will be the complementary of the susceptible frequency considering the total number tested, describing both frequencies is unnecessary.

6. Page 15-16, line 150-162, as part of ESBL gene analysis only two genes, bla-TEM and bla-CTXM were analyzed.

a) Some more genes should be included to draw conclusions about ESBL associated resistance.

b) There was no description about the type of bla-CTXM (type-9/ 15?).

c) There should be statistical analyses to see the association of the bla-TEM and bla-CTXM genes with the bacterial phenotypic resistance phenomena.

d) Not clear why colistin resistance gene, mcr-1 was analyzed under the titleship of ESBL. Need justification at the introduction and discussion.

7. For performing AST, authors should use at least one or two ATCC controls to validate and interpret their result.

8. This study lacks novelty as many other previous studies reported bla-TEM and bla-CTXM in poultry samples all over the globe.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Ripan Biswas

Reviewer #2: Yes: Professor. Dr. Md. Salequl Islam.

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-22-25669-Review comments-Salequl.docx

PLoS One. 2023 May 19;18(5):e0285743. doi: 10.1371/journal.pone.0285743.r002

Author response to Decision Letter 0


20 Apr 2023

Reviewer #1:The following corrections are to be made.

Line 17- excessive may be exchanged with overuse.

Response , thank you for the suggestion corrected accordingly

Line 38: Modern food animal production system requires large amounts

Response , thank you for the correction corrected accordingly

Line 49: also found in Salmonella.

Response, Thank you for the suggestion and corrected accordingly

Line 53: directly or indirectly be transferred to humans through (happens vice versa)

Response , Thank you for the suggestion corrected accordingly

Line 66: from chicken farm but there is no

Response, thank you for the suggestion corrected accordingly

Line 68: Therefore, this study was aimed

Response, thank you for the correction and corrected accordingly

Line 75: in Amies transport medium and labeled

Response, thank you for the correction corrected accordingly

Line 80: 24 hrs.

Response, thank you for the correction corrected accordingly

Line 82: 24 hrs.

Response, thank you for the correction corrected accordingly

Line 83: confirmation by using biochemical characteristics.

Response, thank you for the Suggestion corrected accordingly.

Line 86: Agar

Response, thank you for the correction corrected accordingly

Line 114: 4 min,

Response, thank you for the correction corrected accordingly

Line 115: 60 sec and 10 mins

Response, thank you for the correction corrected accordingly

Line 122: The primers used are available in (correct the language)

Response, thank you for the correction corrected accordingly

Line 137: isolates will be in non italic

Response, thank you for the suggestion corrected accordingly

Line 153: Our study showed that

Response, thank you for the suggestion corrected accordingly

Line 179: These results showed that most

Response, thank you for the Suggestion corrected accordingly

Line 198: We found that out of the 97 isolates of E. coli,

Please check all references font and style.

Response, thank you for the correction corrected accordingly.

Attachment

Submitted filename: Response to Reviewers_2.docx

Decision Letter 1

Indranil Samanta

2 May 2023

Molecular Detection and Antimicrobial Resistance Profiles of Extended-Spectrum Beta-Lactamase (ESBL) Producing Escherichia coli in Broiler Chicken Farms in Malaysia

PONE-D-22-25669R1

Dear Dr. Desta,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Indranil Samanta

Academic Editor

PLOS ONE

Additional Editor Comments (optional): The authors have addressed the comments sufficiently

Reviewers' comments:

Acceptance letter

Indranil Samanta

12 May 2023

PONE-D-22-25669R1

Molecular Detection and Antimicrobial Resistance Profiles of Extended-Spectrum Beta-Lactamase (ESBL) Producing Escherichia coli in Broiler Chicken Farms in Malaysia

Dear Dr. Lemlem:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Indranil Samanta

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Data. Contains all supplementary data.

    (CSV)

    S1 File. Contains all the supporting figures.

    (DOCX)

    S2 File. Contain the correlation matrix.

    (IPYNB)

    Attachment

    Submitted filename: PONE-D-22-25669-Review comments-Salequl.docx

    Attachment

    Submitted filename: Response to Reviewers_2.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES